Le Lézard
Classified in: Health
Subjects: TRI, FDA

Shriners Hospitals for Children Announces New Medical Device for Scoliosis Treatment Approved by FDA


PHILADELPHIA, Aug. 16, 2019 /PRNewswire-PRWeb/ -- A new medical device for treating scoliosis, curvature of the spine, has received FDA approval, providing an alternative that both corrects the curve and maintains flexibility in the spine.

The FDA's clearance is for The Tethertm, which uses patented methods and techniques developed by medical staff of Shriners Hospitals for Children® ? Philadelphia. It is the first commercially available product used specifically for VBT, anterior vertebral body tethering, a surgical procedure for patients with scoliosis who meet very specific criteria. VBT is an alternative to spinal fusion procedures.

Children worldwide are affected by scoliosis, and Shriners Hospitals for Children ? Philadelphia has an extensive scoliosis program designed to treat all forms of the condition, using every non-surgical and surgical option available.

Since 2011, the Philadelphia Shriners Hospitals for Children has offered VBT as an option for patients who meet specific criteria. VBT is a promising alternative for certain patients with scoliosis who are still growing and for whom surgery is indicated.

How it works

Instead of using metal rods, VBT uses a strong, flexible cord to gently pull on the outside of a scoliosis curve to straighten the spine. A screw is placed in each vertebra of the curve and then attached to the flexible cord with the spine in a straighter position. Scoliosis progression is stopped, the spine is realigned and can continue to grow, and flexibility is maintained. As the child grows, it is anticipated that curve progression will be halted and the spine will remain straight.

The Tether straightens the spine using the patient's growth process. The pressure from the cord slows the growth on the tall side of the vertebra, so that the short side can grow and catch up. This novel technology allows for both correction and continued motion at the levels of the spine treated, unlike fusion surgeries. As an emerging treatment for a small patient population, this system is being made available through the FDA's humanitarian device exemption (HDE) pathway.

Innovative approach

The Philadelphia Shriners Hospitals for Children medical staff developed the methods and techniques underlying VBT and has worked closely with the FDA and industry partners to bring this product to approval, demonstrating our commitment to transforming the lives of children.

"The ability to utilize a child's growth to correct the curve in their back is a leap in the way these children are treated ? properly selected patients can achieve curve correction while maintaining mobility," said Amer Samdani, chief of surgery, Shriners Hospitals for Children ? Philadelphia.

Customized treatment

Whether a child has common idiopathic adolescent scoliosis or a highly complex spine deformity, they deserve an individualized treatment plan utilizing the most advanced and innovative techniques. The spine team at the Philadelphia Shriners Hospital takes a fully integrated team approach to the treatment of pediatric spine conditions, with a focus on early detection and fusionless treatments for the growing spine, as well as offering minimally invasive and advanced surgical techniques for those children who require spinal fusions.

Shriners Hospitals for Children is committed to offering our patients high quality, compassionate care and the most innovative treatment options in order for them to have the best chance for full recovery and the ability to pursue their dreams.

About Shriners Hospitals for Children

Shriners Hospitals for Children improves the lives of children by providing pediatric specialty care, conducting innovative research, and offering outstanding educational programs for medical professionals. Children with orthopaedic conditions, burns, spinal cord injuries, and cleft lip and palate are eligible for care, regardless of the families' ability to pay, and receive all care and services in a compassionate, family-centered environment. For more information, please visit shrinershospitalsforchildren.org.

Fast facts: Scoliosis

The key in all care and treatments of scoliosis is prevention; the earlier detection happens in children and adolescents, the better possible outcomes.

There are many types of scoliosis:

About Anterior Vertebral Body Tethering

Media Assets:

https://shriners.vids.io/videos/489ddab91214e3cdc0/dr-samdani-vt-fda-mp4

https://shriners.vids.io/videos/a09ddab91215ebc628/vt-fda-broll-mp4

Contact:

Mel Bower, Shriners Hospitals for Children
813-233-6836
mbower(at)shrinenet.org

SOURCE Shriners Hospitals for Children


These press releases may also interest you

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...



News published on and distributed by: